Neil Kumar, Director, Chief Executive Officer, on June 04, 2026, sold 80,000 shares in BridgeBio Pharma (BBIO) for $5,413,289. Following the Form 4 filing with the SEC, Kumar has control over a total of 4,561,774 common shares of the company, with 243,327 shares held directly and 4,318,447 controlled indirectly.
SEC Filing:
Jeff Dyke, Director, President, on June 08, 2026, sold 50,000 shares in Sonic Automotive (SAH) for $4,148,335. Following the Form 4 filing with the SEC, Dyke has control over a total of 705,290 Class A common shares of the company, with 593,668 shares held directly and 111,622 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1043509/000144822826000003/xslF345X05/wk-form4_1780954105.xml
Shu-Hua (Joshua) Yeh, Senior Vice President and Asia General Manager, on June 04, 2026, sold 10,000 shares in Applied Optoelectronics (AAOI) for $2,050,700. Following the Form 4 filing with the SEC, Yeh has control over a total of 452,430 common shares of the company, with 452,430 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1158114/000168316826004624/xslF345X05/ownership.xml
Cameron Brooks, Chief Revenue Officer, on June 04, 2026, sold 1,242 shares in Axon Enterprise (AXON) for $621,000. Following the Form 4 filing with the SEC, Brooks has control over a total of 49,710 common shares of the company, with 49,710 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1069183/000162828026041661/xslF345X05/wk-form4_1780952214.xml